Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Brexpiprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,812Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets
    Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets

    15 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/alembic-pharma-gets-usfda-final-approval-for-brexpiprazole-tablets-0-25-mg-0-5-mg-1-mg-2-mg-3-mg-and-4-mg/

    EXPRESSPHARMA
    15 Jan 2025
    Share Share
    Prinston`s Generics Brexpiprazole Receives Tentative Approval in US
    Prinston`s Generics Brexpiprazole Receives Tentative Approval in US

    21 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213587

    FDA
    21 Oct 2024
    Share Share
    Otsuka And Lundbeck Present REXULTI® Data At AAIC 2024
    Otsuka And Lundbeck Present REXULTI® Data At AAIC 2024

    31 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240731398299/en

    BUSINESSWIRE
    31 Jul 2024
    Share Share
    Otsuka Announce FDA Acceptance of sNDA for Brexpiprazole and Sertraline
    Otsuka Announce FDA Acceptance of sNDA for Brexpiprazole and Sertraline

    25 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240625407910/en

    BUSINESSWIRE
    25 Jun 2024
    Share Share
    Otsuka, Lundbeck: Brexpiprazole Plus Sertraline Data In PTSD Presented
    Otsuka, Lundbeck: Brexpiprazole Plus Sertraline Data In PTSD Presented

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528141173/en

    BUSINESSWIRE
    28 May 2024
    Share Share
    Lundbeck blames DTC blackout for slowdown in Rexulti growth
    Lundbeck blames DTC blackout for slowdown in Rexulti growth

    16 May 2024

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/marketing/lundbeck-blames-fda-imposed-dtc-blackout-slowdown-rexulti-growth

    Nick Paul Taylor FIERCE PHARMA
    16 May 2024
    Share Share